CD8P Stock Overview
An exchange traded fund launched and managed by Amundi Asset Management.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Amundi ETF MSCI EMU High Dividend UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €159.10 |
52 Week High | €159.10 |
52 Week Low | €139.06 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | 20.69% |
5 Year Change | 37.16% |
Change since IPO | 149.14% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
CD8P | GB Capital Markets | GB Market | |
---|---|---|---|
7D | 0% | 0.4% | -1.2% |
1Y | n/a | 11.6% | 4.5% |
Return vs Industry: Insufficient data to determine how CD8P performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how CD8P performed against the UK Market.
Price Volatility
CD8P volatility | |
---|---|
CD8P Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.2% |
10% least volatile stocks in GB Market | 2.8% |
Stable Share Price: CD8P has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CD8P's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | n/a | n/a | n/a |
Amundi ETF MSCI EMU High Dividend UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management. It invests in the public equity markets of the European Economic and Monetary Union (EMU). The fund uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors.
Amundi ETF MSCI EMU High Dividend UCITS ETF Fundamentals Summary
CD8P fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs CD8P overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CD8P income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CD8P perform over the long term?
See historical performance and comparison